Targeting tumor-necrosis factor receptor pathways for tumor immunotherapy

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2051-1426

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Targeting tumor-necrosis factor receptor pathways for tumor immunotherapy ; volume:2 ; number:1 ; day:15 ; month:4 ; year:2014 ; pages:1-9 ; date:12.2014
Journal for ImmunoTherapy of Cancer ; 2, Heft 1 (15.4.2014), 1-9, 12.2014

Creator: Schaer, David A.

Contributor: Hirschhorn-Cymerman, Daniel
Wolchok, Jedd D.
SpringerLink (Online service)

DOI: 10.1186/2051-1426-2-7

URN: urn:nbn:de:1111-2016072656163

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:54 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Schaer, David A.
Hirschhorn-Cymerman, Daniel
Wolchok, Jedd D.
SpringerLink (Online service)

Other Objects (12)

Toward integrative cancer immunotherapy: targeting the tumor microenvironment

Targeting PCSK9 to upregulate MHC-II on the surface of tumor cells in tumor immunotherapy

Targeting the macrophage immunocheckpoint: a novel insight into solid tumor immunotherapy

Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy

Nanomedicine Tumor Targeting

Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells

Tumor‐derived microparticles in tumor immunology and immunotherapy

Basic characterization of antibodies targeting receptors of the tumor necrosis factor receptor superfamily

Polyoxazoline‐Based Nanovaccine Synergizes with Tumor‐Associated Macrophage Targeting and Anti‐PD‐1 Immunotherapy against Solid Tumors

Targeting and repolarizing M2-like tumor-associated macrophage-mediated MR imaging and tumor immunotherapy by biomimetic nanoparticles

Emerging biomaterials for tumor immunotherapy

Toward integrative cancer immunotherapy: targeting the tumor microenvironment

Targeting PCSK9 to upregulate MHC-II on the surface of tumor cells in tumor immunotherapy

Targeting the macrophage immunocheckpoint: a novel insight into solid tumor immunotherapy

Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy

Nanomedicine Tumor Targeting

Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells

Tumor‐derived microparticles in tumor immunology and immunotherapy

Basic characterization of antibodies targeting receptors of the tumor necrosis factor receptor superfamily

Polyoxazoline‐Based Nanovaccine Synergizes with Tumor‐Associated Macrophage Targeting and Anti‐PD‐1 Immunotherapy against Solid Tumors

Targeting and repolarizing M2-like tumor-associated macrophage-mediated MR imaging and tumor immunotherapy by biomimetic nanoparticles

Emerging biomaterials for tumor immunotherapy

Toward integrative cancer immunotherapy: targeting the tumor microenvironment

Targeting PCSK9 to upregulate MHC-II on the surface of tumor cells in tumor immunotherapy

Targeting the macrophage immunocheckpoint: a novel insight into solid tumor immunotherapy

Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy

Nanomedicine Tumor Targeting

Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells

Tumor‐derived microparticles in tumor immunology and immunotherapy

Basic characterization of antibodies targeting receptors of the tumor necrosis factor receptor superfamily

Polyoxazoline‐Based Nanovaccine Synergizes with Tumor‐Associated Macrophage Targeting and Anti‐PD‐1 Immunotherapy against Solid Tumors

Targeting and repolarizing M2-like tumor-associated macrophage-mediated MR imaging and tumor immunotherapy by biomimetic nanoparticles

Emerging biomaterials for tumor immunotherapy

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Targeting tumor-necrosis factor receptor pathways for tumor immunotherapy

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Toward integrative cancer immunotherapy: targeting the tumor microenvironment

Targeting PCSK9 to upregulate MHC-II on the surface of tumor cells in tumor immunotherapy

Targeting the macrophage immunocheckpoint: a novel insight into solid tumor immunotherapy

Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy

Nanomedicine Tumor Targeting

Nanomedicine Tumor Targeting

Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells

Tumor‐derived microparticles in tumor immunology and immunotherapy

Basic characterization of antibodies targeting receptors of the tumor necrosis factor receptor superfamily

Polyoxazoline‐Based Nanovaccine Synergizes with Tumor‐Associated Macrophage Targeting and Anti‐PD‐1 Immunotherapy against Solid Tumors

Targeting and repolarizing M2-like tumor-associated macrophage-mediated MR imaging and tumor immunotherapy by biomimetic nanoparticles

Emerging biomaterials for tumor immunotherapy

Toward integrative cancer immunotherapy: targeting the tumor microenvironment

Targeting PCSK9 to upregulate MHC-II on the surface of tumor cells in tumor immunotherapy

Targeting the macrophage immunocheckpoint: a novel insight into solid tumor immunotherapy

Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy

Nanomedicine Tumor Targeting

Nanomedicine Tumor Targeting

Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells

Tumor‐derived microparticles in tumor immunology and immunotherapy

Basic characterization of antibodies targeting receptors of the tumor necrosis factor receptor superfamily

Polyoxazoline‐Based Nanovaccine Synergizes with Tumor‐Associated Macrophage Targeting and Anti‐PD‐1 Immunotherapy against Solid Tumors

Targeting and repolarizing M2-like tumor-associated macrophage-mediated MR imaging and tumor immunotherapy by biomimetic nanoparticles

Emerging biomaterials for tumor immunotherapy

Toward integrative cancer immunotherapy: targeting the tumor microenvironment

Targeting PCSK9 to upregulate MHC-II on the surface of tumor cells in tumor immunotherapy

Targeting the macrophage immunocheckpoint: a novel insight into solid tumor immunotherapy

Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy

Nanomedicine Tumor Targeting

Nanomedicine Tumor Targeting

Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells

Tumor‐derived microparticles in tumor immunology and immunotherapy

Basic characterization of antibodies targeting receptors of the tumor necrosis factor receptor superfamily

Polyoxazoline‐Based Nanovaccine Synergizes with Tumor‐Associated Macrophage Targeting and Anti‐PD‐1 Immunotherapy against Solid Tumors

Targeting and repolarizing M2-like tumor-associated macrophage-mediated MR imaging and tumor immunotherapy by biomimetic nanoparticles

Emerging biomaterials for tumor immunotherapy

Related objects

Reset password